JP2023500408A5 - - Google Patents
Info
- Publication number
- JP2023500408A5 JP2023500408A5 JP2022527081A JP2022527081A JP2023500408A5 JP 2023500408 A5 JP2023500408 A5 JP 2023500408A5 JP 2022527081 A JP2022527081 A JP 2022527081A JP 2022527081 A JP2022527081 A JP 2022527081A JP 2023500408 A5 JP2023500408 A5 JP 2023500408A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- compound according
- disease
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025126773A JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962934293P | 2019-11-12 | 2019-11-12 | |
| US62/934,293 | 2019-11-12 | ||
| PCT/US2020/060180 WO2021097057A1 (en) | 2019-11-12 | 2020-11-12 | 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient cftr activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126773A Division JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500408A JP2023500408A (ja) | 2023-01-05 |
| JP2023500408A5 true JP2023500408A5 (enExample) | 2023-11-20 |
| JP7721517B2 JP7721517B2 (ja) | 2025-08-12 |
Family
ID=73740547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527081A Active JP7721517B2 (ja) | 2019-11-12 | 2020-11-12 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
| JP2025126773A Pending JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126773A Pending JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240002374A1 (enExample) |
| EP (1) | EP4058439A1 (enExample) |
| JP (2) | JP7721517B2 (enExample) |
| KR (2) | KR20260078949A (enExample) |
| CN (2) | CN122562796A (enExample) |
| AU (1) | AU2020384279A1 (enExample) |
| BR (1) | BR112022009185A2 (enExample) |
| CA (1) | CA3158057A1 (enExample) |
| CL (1) | CL2022001245A1 (enExample) |
| CO (1) | CO2022007953A2 (enExample) |
| EC (1) | ECSP22046050A (enExample) |
| IL (1) | IL292966A (enExample) |
| JO (1) | JOP20220105A1 (enExample) |
| MX (1) | MX2022005809A (enExample) |
| PE (1) | PE20221461A1 (enExample) |
| PH (1) | PH12022551139A1 (enExample) |
| WO (1) | WO2021097057A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS64018B1 (sr) | 2018-02-15 | 2023-03-31 | Vertex Pharma | Makrocikli kao modulatori transmembranskog regulatora provodnosti cistične fibroze, njihove farmaceutske kompozicije, njihova upotreba u lečenju cistične fibroze i proces njihove izrade |
| TWI848092B (zh) | 2019-04-03 | 2024-07-11 | 美商維泰克斯製藥公司 | 囊腫纖維化跨膜傳導調節蛋白調節劑 |
| US11873300B2 (en) | 2019-08-14 | 2024-01-16 | Vertex Pharmaceuticals Incorporated | Crystalline forms of CFTR modulators |
| TWI867024B (zh) | 2019-08-14 | 2024-12-21 | 美商維泰克斯製藥公司 | 囊腫纖維化跨膜傳導調節蛋白之調節劑 |
| TWI899097B (zh) | 2019-08-14 | 2025-10-01 | 美商維泰克斯製藥公司 | 製備cftr調節劑之方法 |
| MX2022005810A (es) | 2019-11-12 | 2022-06-08 | Genzyme Corp | Heteroarilaminosulfonamidas de 6 miembros para tratar enfermedades y afecciones mediadas por la actividad de regulador de la conductancia transmembrana de la fibrosis quistica (cftr) deficiente. |
| WO2021113806A1 (en) | 2019-12-05 | 2021-06-10 | Genzyme Corporation | Arylamides and methods of use thereof |
| WO2021113808A1 (en) | 2019-12-05 | 2021-06-10 | Genzyme Corporation | Cftr-modulating arylamides |
| WO2021113809A1 (en) | 2019-12-05 | 2021-06-10 | Genzyme Corporation | Arylamides and methods of use thereof |
| WO2022076628A1 (en) * | 2020-10-07 | 2022-04-14 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| MX2023006770A (es) | 2020-12-10 | 2023-08-14 | Vertex Pharma | Metodos de tratamiento para fibrosis quistica. |
| CN113480416B (zh) * | 2021-07-12 | 2023-03-21 | 重庆大学 | 一种芳基酮的制备方法 |
| IL315190A (en) | 2022-03-30 | 2024-10-01 | Ishihara Sangyo Kaisha | A pyridazinone compound or a salt thereof and a pesticide containing them |
| CN114835655A (zh) * | 2022-04-14 | 2022-08-02 | 河南师范大学 | 一种合成光学活性三氟甲基丙烯酸酯类化合物的方法 |
| EP4611742A1 (en) | 2022-10-31 | 2025-09-10 | Sionna Therapeutics Inc. | Methods of treating cftr-mediated diseases or disorders |
| EP4746882A1 (en) * | 2023-07-20 | 2026-05-27 | CeMM - Forschungszentrum für Molekulare Medizin GmbH | Inhibitors of smndc1 and their therapeutic use |
| CN122374316A (zh) | 2023-10-04 | 2026-07-10 | 弗特克斯药品有限公司 | 囊性纤维化跨膜传导调控因子的调节剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU654125B2 (en) * | 1991-03-07 | 1994-10-27 | Hisamitsu Pharmaceutical Co., Inc. | Novel diphenylthyazole derivative |
| EP0790057B1 (en) * | 1994-11-29 | 2002-06-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
| JP2005510508A (ja) * | 2001-11-08 | 2005-04-21 | 藤沢薬品工業株式会社 | アデノシンアンタゴニストとしてのチアゾールピリダジノン類 |
| US7973169B2 (en) | 2003-09-06 | 2011-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| AU2012267732A1 (en) | 2011-06-10 | 2014-01-09 | Medimmune Limited | Anti-Pseudomonas Psl binding molecules and uses thereof |
| WO2016183173A1 (en) * | 2015-05-12 | 2016-11-17 | Avista Pharma Solutions | Antiparasitic compounds |
| US10138227B2 (en) * | 2016-06-03 | 2018-11-27 | Abbvie S.Á.R.L. | Heteroaryl substituted pyridines and methods of use |
| TW201811766A (zh) * | 2016-08-29 | 2018-04-01 | 瑞士商諾華公司 | N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途 |
| EP4611742A1 (en) * | 2022-10-31 | 2025-09-10 | Sionna Therapeutics Inc. | Methods of treating cftr-mediated diseases or disorders |
-
2020
- 2020-11-12 CA CA3158057A patent/CA3158057A1/en active Pending
- 2020-11-12 MX MX2022005809A patent/MX2022005809A/es unknown
- 2020-11-12 CN CN202610573511.5A patent/CN122562796A/zh active Pending
- 2020-11-12 EP EP20820656.5A patent/EP4058439A1/en active Pending
- 2020-11-12 BR BR112022009185A patent/BR112022009185A2/pt unknown
- 2020-11-12 AU AU2020384279A patent/AU2020384279A1/en active Pending
- 2020-11-12 CN CN202080092755.2A patent/CN115003659B/zh active Active
- 2020-11-12 PE PE2022000772A patent/PE20221461A1/es unknown
- 2020-11-12 JP JP2022527081A patent/JP7721517B2/ja active Active
- 2020-11-12 KR KR1020267014545A patent/KR20260078949A/ko active Pending
- 2020-11-12 IL IL292966A patent/IL292966A/en unknown
- 2020-11-12 WO PCT/US2020/060180 patent/WO2021097057A1/en not_active Ceased
- 2020-11-12 KR KR1020227019502A patent/KR102964196B1/ko active Active
- 2020-11-12 PH PH1/2022/551139A patent/PH12022551139A1/en unknown
-
2022
- 2022-05-10 JO JOP/2022/0105A patent/JOP20220105A1/ar unknown
- 2022-05-11 US US17/742,169 patent/US20240002374A1/en active Pending
- 2022-05-12 CL CL2022001245A patent/CL2022001245A1/es unknown
- 2022-06-03 CO CONC2022/0007953A patent/CO2022007953A2/es unknown
- 2022-06-09 EC ECSENADI202246050A patent/ECSP22046050A/es unknown
-
2025
- 2025-07-30 JP JP2025126773A patent/JP2025160375A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7721517B2 (ja) | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド | |
| JP2019513741A5 (enExample) | ||
| JP2013513617A5 (enExample) | ||
| RU2012129206A (ru) | Модуляторы атф-связывающих транспортеров | |
| ME02799B (me) | Modulatori ATP-vezujućih kasetnih transportera | |
| CN107207487B (zh) | 用于提高cftr活性的化合物、组合物和方法 | |
| KR102448404B1 (ko) | 규소 원자 함유 이바카프터 유사체 | |
| AU2020281069B2 (en) | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| JP2013532662A5 (enExample) | ||
| WO2024097227A1 (en) | Methods of treating cftr-mediated diseases or disorders | |
| JP2023519241A5 (enExample) | ||
| JP2009522277A5 (enExample) | ||
| HRP20160682T1 (hr) | Čvrsti oblici 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzojeve kiseline | |
| RU2014134456A (ru) | Препараты 3-(6-(1-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| RU2018116569A (ru) | Соединения, композиции и способы для модуляции cftr | |
| RU2012147272A (ru) | Фармацевтические композиции, включающие 3-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойную кислоту, и их введение | |
| BR112013029240B1 (pt) | Composto derivado deuterado do ivacaftor, composição que o compreende e usos dos mesmos | |
| AU2014267220A1 (en) | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| TW201920153A (zh) | 具有環狀構造的化合物 | |
| RU2009121812A (ru) | Производные 5-гидроксиметилоксазолидин-2-она | |
| WO2023125825A1 (en) | Anticoronviral compounds and compositions and uses thereof | |
| US20120328661A1 (en) | Coumarin compounds as receptor modulators with therapeutic utility | |
| WO2025189008A1 (en) | Methods of treating cftr-mediated diseases or disorders | |
| KR100652470B1 (ko) | 사이클로알킬 치환 아미노메틸피롤리딘 유도체 | |
| ES2238723T3 (es) | Derivados de aminociclopropano cis-sustituidos. |